• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾丸癌腹膜后淋巴结清扫术的医院手术量、利用率、成本及结果

Hospital surgical volume, utilization, costs and outcomes of retroperitoneal lymph node dissection for testis cancer.

作者信息

Yu Hua-Yin, Hevelone Nathanael D, Patel Sunil, Lipsitz Stuart R, Hu Jim C

机构信息

Division of Urology, Brigham and Women's Hospital, Harvard Medical School, 1153 Centre Street, Suite 4420, Boston, MA 02130, USA.

出版信息

Adv Urol. 2012;2012:189823. doi: 10.1155/2012/189823. Epub 2012 Apr 9.

DOI:10.1155/2012/189823
PMID:22550481
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3328891/
Abstract

Objectives. Retroperitoneal lymph node dissection (RPLND) outcomes for testis cancer originate mostly from single-center series. We characterized population-based utilization, costs, and outcomes and assessed whether higher volume affects outcomes. Methods and Materials. Using the US Nationwide Inpatient Sample from 2001-2008, we identified 993 RPLND and used propensity score methods to assess utilization, costs, and inpatient outcomes based on hospital surgical volume. Results. 51.6% of RPLND were performed at hospitals where there were two or fewer cases per year. RPLND was more commonly performed at large urban teaching hospitals, where men were younger, more likely to be white and earning incomes exceeding the 50th percentile (all P ≤ .05). Higher hospital volumes were associated with fewer complications and more routine home discharges (all P ≤ .047). However, higher volume hospitals had more transfusions (P = .004) and incurred $1,435 more in median costs (P < .001). Limitations include inability to adjust for tumor characteristics and absence of outpatient outcomes. Conclusions. Sociodemographic differences exist between high versus low volume RPLND hospitals. Although higher volume hospitals had more transfusions and higher costs, perhaps due to more complex cases, they experienced fewer complications. However, most RPLND are performed at hospitals where there were two or fewer cases per year.

摘要

目的。睾丸癌的腹膜后淋巴结清扫术(RPLND)结果大多来自单中心系列研究。我们描述了基于人群的手术应用情况、成本和结果,并评估了手术量较高是否会影响结果。方法和材料。利用2001 - 2008年美国全国住院患者样本,我们识别出993例RPLND手术,并使用倾向评分方法根据医院手术量评估手术应用情况、成本和住院结果。结果。51.6%的RPLND手术是在每年病例数为2例或更少的医院进行的。RPLND手术在大型城市教学医院更常进行,这些医院的男性患者更年轻,更可能是白人,收入超过第50百分位数(所有P≤0.05)。医院手术量较高与并发症较少和更多常规出院回家相关(所有P≤0.047)。然而,手术量较高的医院输血更多(P = 0.004),中位成本高出1435美元(P < 0.001)。局限性包括无法调整肿瘤特征以及缺乏门诊结果。结论。RPLND手术量高的医院和低的医院之间存在社会人口统计学差异。尽管手术量较高的医院输血更多且成本更高,这可能是由于病例更复杂,但它们的并发症较少。然而,大多数RPLND手术是在每年病例数为2例或更少的医院进行的。

相似文献

1
Hospital surgical volume, utilization, costs and outcomes of retroperitoneal lymph node dissection for testis cancer.睾丸癌腹膜后淋巴结清扫术的医院手术量、利用率、成本及结果
Adv Urol. 2012;2012:189823. doi: 10.1155/2012/189823. Epub 2012 Apr 9.
2
Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors.基于人群的原发性腹膜后淋巴结清扫术治疗生殖细胞肿瘤的开放式和机器人手术的成本和围手术期结局分析。
World J Urol. 2021 Jun;39(6):1977-1984. doi: 10.1007/s00345-020-03403-9. Epub 2020 Aug 14.
3
Contemporary retroperitoneal lymph node dissection (RPLND) for testis cancer in the UK - a national study.英国睾丸癌的当代腹膜后淋巴结清扫术(RPLND)——一项全国性研究。
BJU Int. 2017 Jan;119(1):91-99. doi: 10.1111/bju.13569. Epub 2016 Jul 30.
4
[Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis].[化疗后腹膜后淋巴结清扫术的临床结果及预测睾丸晚期非精原细胞瘤腹膜后组织学情况]
Zhonghua Wai Ke Za Zhi. 2017 Aug 1;55(8):603-607. doi: 10.3760/cma.j.issn.0529-5815.2017.08.010.
5
Nationwide Patterns of Care for Stage II Nonseminomatous Germ Cell Tumor of the Testicle.全国范围内对睾丸 II 期非精原细胞瘤的治疗模式。
Eur Urol Oncol. 2020 Apr;3(2):198-206. doi: 10.1016/j.euo.2019.06.007. Epub 2019 Jul 1.
6
Centralization tendencies of retroperitoneal lymph node dissection for testicular cancer in Germany? A total population-based analysis from 2006 to 2015.德国睾丸癌腹膜后淋巴结清扫术的集中化趋势?2006 年至 2015 年的全人群分析。
World J Urol. 2020 Jul;38(7):1765-1772. doi: 10.1007/s00345-019-02972-8. Epub 2019 Oct 11.
7
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.化疗后腹膜后淋巴结清扫术治疗非精原细胞瘤生殖细胞肿瘤的手术并发症:瑞典挪威睾丸癌组的一项基于人群的研究。
Eur Urol Oncol. 2020 Jun;3(3):382-389. doi: 10.1016/j.euo.2019.08.002. Epub 2019 Sep 8.
8
Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique.机器人辅助腹腔镜腹膜后淋巴结清扫术治疗睾丸癌:技术的演变。
Eur Urol. 2016 Oct;70(4):661-667. doi: 10.1016/j.eururo.2016.03.031. Epub 2016 Apr 5.
9
Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity.中腹部腹膜外入路在睾丸癌腹膜后淋巴结清扫术中的应用:降低手术并发症。
Eur Urol. 2017 Nov;72(5):814-820. doi: 10.1016/j.eururo.2017.02.024. Epub 2017 Mar 18.
10
Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.机器人辅助腹膜后淋巴结清扫术治疗睾丸癌患者的手术不良结局。
Eur Urol. 2019 Nov;76(5):607-609. doi: 10.1016/j.eururo.2019.05.031. Epub 2019 Jun 4.

引用本文的文献

1
Feasibility and Oncological Safety of Robotic Retroperitoneal Lymph Node Dissection in Patients with Testicular Cancer-Single-Center Experience.睾丸癌患者机器人腹膜后淋巴结清扫术的可行性及肿瘤学安全性——单中心经验
Cancers (Basel). 2025 Apr 25;17(9):1439. doi: 10.3390/cancers17091439.
2
Assessing complications from retroperitoneal lymph node dissection for testicular cancer in North America.评估北美地区睾丸癌腹膜后淋巴结清扫术的并发症
Can Urol Assoc J. 2025 Jun;19(6):167-172. doi: 10.5489/cuaj.9042.
3
Post-Chemotherapy Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer at a National Referral Centre.国家转诊中心针对转移性睾丸癌的化疗后腹膜后淋巴结清扫术
Cancers (Basel). 2025 Feb 11;17(4):608. doi: 10.3390/cancers17040608.
4
Hospital-Level Patterns of Retroperitoneal Lymph Node Dissection Surgeries: Are Recommendations for High-Volume Cention Being Followed?医院层面的腹膜后淋巴结清扫手术模式:关于高容量中心的建议是否得到遵循?
J Urol. 2025 Jun;213(6):786-788. doi: 10.1097/JU.0000000000004477. Epub 2025 Feb 13.
5
Retroperitoneal lymph node dissection for testicular cancer is a demanding procedure: detailed real-life data of complications and additional surgical procedures in 295 cases.腹膜后淋巴结清扫术治疗睾丸癌是一项要求很高的手术:295 例并发症和附加手术的详细真实数据。
World J Urol. 2023 Sep;41(9):2397-2404. doi: 10.1007/s00345-023-04516-7. Epub 2023 Jul 25.
6
Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set.英国一家大型中心与全国数据集相比,化疗后腹膜后淋巴结清扫术的结果
Eur Urol Open Sci. 2021 Sep 30;33:83-88. doi: 10.1016/j.euros.2021.09.005. eCollection 2021 Nov.
7
Population-based analysis of cost and peri-operative outcomes between open and robotic primary retroperitoneal lymph node dissection for germ cell tumors.基于人群的原发性腹膜后淋巴结清扫术治疗生殖细胞肿瘤的开放式和机器人手术的成本和围手术期结局分析。
World J Urol. 2021 Jun;39(6):1977-1984. doi: 10.1007/s00345-020-03403-9. Epub 2020 Aug 14.
8
Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum.腹膜后泌尿生殖系统癌的复杂手术和围手术期全身治疗。
Curr Oncol. 2020 Feb;27(1):e34-e42. doi: 10.3747/co.27.5713. Epub 2020 Feb 1.
9
A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer.机器人辅助腹腔镜下睾丸癌腹膜后淋巴结清扫术的结果与技术综述
Adv Urol. 2018 May 3;2018:2146080. doi: 10.1155/2018/2146080. eCollection 2018.
10
Association of High-Volume Surgeons Working in High-Volume Hospitals with Cost of Free Flap Surgeries.在高流量医院工作的高手术量外科医生与游离皮瓣手术费用的关联。
Plast Reconstr Surg Glob Open. 2017 Oct 25;5(10):e1520. doi: 10.1097/GOX.0000000000001520. eCollection 2017 Oct.

本文引用的文献

1
Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.腹膜后淋巴结清扫术在睾丸非精原细胞瘤患者中的应用趋势:一项基于人群的研究。
Ann Surg Oncol. 2011 Oct;18(10):2997-3004. doi: 10.1245/s10434-011-1722-3. Epub 2011 Apr 21.
2
Wide variation in hospital and physician payment rates evidence of provider market power.医院和医生支付费率存在广泛差异,这证明了供应商的市场力量。
Res Brief. 2010 Nov(16):1-11.
3
Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.临床分期为IS期睾丸癌患者的原发性腹膜后淋巴结清扫术。
J Urol. 2009 Dec;182(6):2716-20. doi: 10.1016/j.juro.2009.08.038.
4
Comparative effectiveness of minimally invasive vs open radical prostatectomy.微创与开放性根治性前列腺切除术的比较疗效
JAMA. 2009 Oct 14;302(14):1557-64. doi: 10.1001/jama.2009.1451.
5
Disparities in the utilization of high-volume hospitals for complex surgery.复杂手术中高容量医院利用情况的差异。
JAMA. 2006 Oct 25;296(16):1973-80. doi: 10.1001/jama.296.16.1973.
6
A comparison of comorbidity measurements to predict healthcare expenditures.用于预测医疗保健支出的共病测量方法比较。
Am J Manag Care. 2006 Feb;12(2):110-9.
7
Trends in testicular cancer incidence and mortality in 22 European countries: continuing increases in incidence and declines in mortality.22个欧洲国家睾丸癌发病率和死亡率的趋势:发病率持续上升,死亡率持续下降。
Int J Cancer. 2006 Jun 15;118(12):3099-111. doi: 10.1002/ijc.21747.
8
The impact of provider volume on outcomes from urological cancer therapy.医疗服务提供者的治疗量对泌尿生殖系统癌症治疗结果的影响。
J Urol. 2005 Aug;174(2):432-8. doi: 10.1097/01.ju.0000165340.53381.48.
9
Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.非精原细胞性生殖细胞睾丸癌的腹膜后淋巴结清扫术:患者选择因素对预后的影响。
J Clin Oncol. 2005 Apr 20;23(12):2781-8. doi: 10.1200/JCO.2005.07.132.
10
Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project.医院及外科医生手术量对根治性膀胱切除术后住院死亡率的影响:来自医疗保健利用项目的数据
J Urol. 2005 May;173(5):1695-700. doi: 10.1097/01.ju.0000154638.61621.03.